Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

OBJECTIVE: Toward the limited real-world data concerning the treatment response to brand direct-acting antiviral agents (DAAs) therapy, we proposed to evaluate the efficacy and safety of DAAs for the treatment of chronic hepatitis C virus (HCV) in mainland China. METHODS: In this retrospective, sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Huan, Lu, Chengzhen, Wang, Yin, Zaongo, Silvere D., Hu, Yue, Wu, Yue, Yan, Zhongfang, Ma, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248196/
https://www.ncbi.nlm.nih.gov/pubmed/32508646
http://dx.doi.org/10.3389/fphar.2020.00710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248196/
https://www.ncbi.nlm.nih.gov/pubmed/32508646
http://dx.doi.org/10.3389/fphar.2020.00710

Ejemplares similares